Stress-related Epstein-Barr virus reactivation. 2010

Omer Coskun, and Kenan Sener, and Selim Kilic, and Hakan Erdem, and Halil Yaman, and Ahmet Bulent Besirbellioglu, and Hanefi Cem Gul, and Can Polat Eyigun
Department of Infectious Diseases and Clinical Microbiology, Gulhane Medical Academy, Enf. Hast. ve Kl. Mik. A.D. Gulhane Askeri Tip Akademisi, Etlik, 06018, Ankara, Turkey. coskunomer23@hotmail.com

Epstein-Barr virus (EBV) remains latent in 90% of the patients following primary infection. The infection might be reactivated due to various stress factors. We, therefore, examined the levels of stress hormones (epinephrine, norepinephrine and cortisol), viral capsid antigen (VCA) immunoglobulin Ig G, VCA IgM, EBV early antigen IgG, Epstein-Barr nuclear antigen (EBNA) IgG, EBNA IgM antibody screening tests and performed EBV polymerized chain reaction (PCR) test and EBV DNA PCR in 100 draftees on their first day of recruitment and at the end of 1 month. Examination of the initial samples revealed that 94 (94%) subjects previously had EBV infection and 6 (6%) were seronegative. Second samples obtained at the end of first month showed that 7 (7.4%) reactivations occurred in 94 subjects who previously had EBV infection (P < 0.001). Two out of six (33.3%) who were initially seronegative had acute infection (P = 0.289). There was no significant difference between the median values of the levels of stress hormones in the initial and second serum and plasma samples. There was a significant difference between the rates of acute infection and reactivation among subjects with elevated cortisol and epinephrine levels in the second samples compared to subjects with normal levels (P < 0.001). No significant difference was determined between the first and second sample hormone levels of all nine subjects whose EBV-DNA turned positive. Routine examinations might not reveal any specific findings since EBV infection often has an asymptomatic course. EBV reactivations should always be kept in mind in patients subject to such stressful conditions.

UI MeSH Term Description Entries
D008137 Longitudinal Studies Studies in which variables relating to an individual or group of individuals are assessed over a period of time. Bogalusa Heart Study,California Teachers Study,Framingham Heart Study,Jackson Heart Study,Longitudinal Survey,Tuskegee Syphilis Study,Bogalusa Heart Studies,California Teachers Studies,Framingham Heart Studies,Heart Studies, Bogalusa,Heart Studies, Framingham,Heart Studies, Jackson,Heart Study, Bogalusa,Heart Study, Framingham,Heart Study, Jackson,Jackson Heart Studies,Longitudinal Study,Longitudinal Surveys,Studies, Bogalusa Heart,Studies, California Teachers,Studies, Jackson Heart,Studies, Longitudinal,Study, Bogalusa Heart,Study, California Teachers,Study, Longitudinal,Survey, Longitudinal,Surveys, Longitudinal,Syphilis Studies, Tuskegee,Syphilis Study, Tuskegee,Teachers Studies, California,Teachers Study, California,Tuskegee Syphilis Studies
D008297 Male Males
D008889 Military Personnel Persons including soldiers involved with the armed forces. Air Force Personnel,Armed Forces Personnel,Army Personnel,Coast Guard,Marines,Navy Personnel,Sailors,Soldiers,Submariners,Military,Force Personnel, Air,Personnel, Air Force,Personnel, Armed Forces,Personnel, Army,Personnel, Military,Personnel, Navy,Sailor,Soldier,Submariner
D004279 DNA, Viral Deoxyribonucleic acid that makes up the genetic material of viruses. Viral DNA
D004854 Herpesvirus 4, Human The type species of LYMPHOCRYPTOVIRUS, subfamily GAMMAHERPESVIRINAE, infecting B-cells in humans. It is thought to be the causative agent of INFECTIOUS MONONUCLEOSIS and is strongly associated with oral hairy leukoplakia (LEUKOPLAKIA, HAIRY;), BURKITT LYMPHOMA; and other malignancies. Burkitt Herpesvirus,Burkitt Lymphoma Virus,E-B Virus,EBV,Epstein-Barr Virus,Human Herpesvirus 4,Infectious Mononucleosis Virus,Burkitt's Lymphoma Virus,HHV-4,Herpesvirus 4 (gamma), Human,Burkitts Lymphoma Virus,E B Virus,E-B Viruses,Epstein Barr Virus,Herpesvirus, Burkitt,Infectious Mononucleosis Viruses,Lymphoma Virus, Burkitt,Mononucleosis Virus, Infectious,Mononucleosis Viruses, Infectious
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000322 Adrenergic Agonists Drugs that bind to and activate adrenergic receptors. Adrenomimetics,Adrenergic Agonist,Adrenergic Receptor Agonist,Adrenergic Receptor Agonists,Receptor Agonists, Adrenergic,Agonist, Adrenergic,Agonist, Adrenergic Receptor,Agonists, Adrenergic,Agonists, Adrenergic Receptor,Receptor Agonist, Adrenergic
D000914 Antibodies, Viral Immunoglobulins produced in response to VIRAL ANTIGENS. Viral Antibodies
D000956 Antigens, Viral Substances elaborated by viruses that have antigenic activity. Viral Antigen,Viral Antigens,Antigen, Viral

Related Publications

Omer Coskun, and Kenan Sener, and Selim Kilic, and Hakan Erdem, and Halil Yaman, and Ahmet Bulent Besirbellioglu, and Hanefi Cem Gul, and Can Polat Eyigun
September 2021, Biomolecules,
Omer Coskun, and Kenan Sener, and Selim Kilic, and Hakan Erdem, and Halil Yaman, and Ahmet Bulent Besirbellioglu, and Hanefi Cem Gul, and Can Polat Eyigun
May 2003, The Lancet. Infectious diseases,
Omer Coskun, and Kenan Sener, and Selim Kilic, and Hakan Erdem, and Halil Yaman, and Ahmet Bulent Besirbellioglu, and Hanefi Cem Gul, and Can Polat Eyigun
January 2000, Neuroimmunomodulation,
Omer Coskun, and Kenan Sener, and Selim Kilic, and Hakan Erdem, and Halil Yaman, and Ahmet Bulent Besirbellioglu, and Hanefi Cem Gul, and Can Polat Eyigun
January 2015, Current topics in microbiology and immunology,
Omer Coskun, and Kenan Sener, and Selim Kilic, and Hakan Erdem, and Halil Yaman, and Ahmet Bulent Besirbellioglu, and Hanefi Cem Gul, and Can Polat Eyigun
June 1991, Brain, behavior, and immunity,
Omer Coskun, and Kenan Sener, and Selim Kilic, and Hakan Erdem, and Halil Yaman, and Ahmet Bulent Besirbellioglu, and Hanefi Cem Gul, and Can Polat Eyigun
September 2023, Clinical case reports,
Omer Coskun, and Kenan Sener, and Selim Kilic, and Hakan Erdem, and Halil Yaman, and Ahmet Bulent Besirbellioglu, and Hanefi Cem Gul, and Can Polat Eyigun
January 2003, European review for medical and pharmacological sciences,
Omer Coskun, and Kenan Sener, and Selim Kilic, and Hakan Erdem, and Halil Yaman, and Ahmet Bulent Besirbellioglu, and Hanefi Cem Gul, and Can Polat Eyigun
January 2005, Reviews in medical virology,
Omer Coskun, and Kenan Sener, and Selim Kilic, and Hakan Erdem, and Halil Yaman, and Ahmet Bulent Besirbellioglu, and Hanefi Cem Gul, and Can Polat Eyigun
April 2022, Cureus,
Omer Coskun, and Kenan Sener, and Selim Kilic, and Hakan Erdem, and Halil Yaman, and Ahmet Bulent Besirbellioglu, and Hanefi Cem Gul, and Can Polat Eyigun
March 1996, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc,
Copied contents to your clipboard!